BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23828406)

  • 1. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
    Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.
    von Mensdorff-Pouilly S; Verstraeten AA; Kenemans P; Snijdewint FG; Kok A; Van Kamp GJ; Paul MA; Van Diest PJ; Meijer S; Hilgers J
    J Clin Oncol; 2000 Feb; 18(3):574-83. PubMed ID: 10653872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
    Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer.
    Tang Y; Cui X; Xiao H; Qi S; Hu X; Yu Q; Shi G; Zhang X; Gu J; Yu Y; Wang L; Li Y
    Mol Med Rep; 2017 May; 15(5):2659-2664. PubMed ID: 28447743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer.
    Hamanaka Y; Suehiro Y; Fukui M; Shikichi K; Imai K; Hinoda Y
    Int J Cancer; 2003 Jan; 103(1):97-100. PubMed ID: 12455059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
    Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
    Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.
    Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L
    Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
    Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
    Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
    [No Abstract]   [Full Text] [Related]  

  • 12. A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancer.
    Pandey JP; Nietert PJ; Klaamas K; Kurtenkov O
    Cancer Immunol Immunother; 2009 Dec; 58(12):2025-9. PubMed ID: 19365631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening.
    Laidi F; Bouziane A; Errachid A; Zaoui F
    Asian Pac J Cancer Prev; 2016; 17(1):335-9. PubMed ID: 26838233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics.
    Guillen-Poza PA; Sánchez-Fernández EM; Artigas G; García Fernández JM; Hinou H; Ortiz Mellet C; Nishimura SI; Garcia-Martin F
    J Med Chem; 2020 Aug; 63(15):8524-8533. PubMed ID: 32672464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic differences between metastatic cells in bone marrow and primary tumours and the anti-MUC1 humoral immune response induced in breast cancer patients.
    Croce MV; Isla-Larrain M; Tur R; Rabassa ME; Segal-Eiras A
    Clin Exp Metastasis; 2004; 21(2):139-47. PubMed ID: 15168731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women.
    Croce MV; Isla-Larrain MT; Capafons A; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2001 Sep; 69(1):1-11. PubMed ID: 11759823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; Livingston PO; Hilgers J; Kenemans P
    Int J Cancer; 2001 Jul; 93(1):97-106. PubMed ID: 11391628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fcγ receptor genes.
    Pandey JP; Namboodiri AM; Wolf B; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Immunobiology; 2018 Feb; 223(2):178-182. PubMed ID: 29074302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.